Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Schiff

Showing results (161-170 of 305) with videos related to

Pageof 31
Sort By:
Acta Neurochirurgica|August 17, 2010
MR imaging characteristics of oligodendroglial tumors with assessment of 1p/19q deletion statusJonathan H Sherman, Daniel M Prevedello, Lubdha Shah, et al.
Cell Cycle (Georgetown, Tex.)|October 5, 2013
microRNA-34a promotes DNA damage and mitotic catastropheAlexander V Kofman, Jungeun Kim, So Yeon Park, et al.
Journal of Neurosurgery|October 25, 2014
Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO reviewLeland Rogers, Igor Barani, Marc Chamberlain, et al.
Mutation Research|July 29, 2018
Improved molecular karyotyping in glioblastomaIan E Burbulis, Margaret B Wierman, Matt Wolpert, et al.
American Journal of Clinical Oncology|September 17, 2016
Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397)Paul L Moots, Anne O'Neill, Harold Londer, et al.
The Prostate|March 13, 2025
Incidental Brain Metastases From Prostate Cancer Diagnosed With PSMA PET/CT and MRI: A Case Series and Literature ReviewMark Willy L Mondia, Prem P Batchala, Robert Dreicer, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 7, 2007
Functional and molecular interactions between the HGF/c-Met pathway and c-Myc in large-cell medulloblastomaYunqing Li, Fadila Guessous, Elizabeth B Johnson, et al.
The Journal of Clinical Endocrinology and Metabolism|July 30, 2010
Temozolomide treatment for aggressive pituitary tumors: correlation of clinical outcome with O(6)-methylguanine methyltransferase (MGMT) promoter methylation and expressionZachary M Bush, Janina A Longtine, Tracy Cunningham, et al.
Oncotarget|February 9, 2018
Phase II study of rituximab given in conjunction with standard chemotherapy in primary central nervous system lymphoma (PCNSL): a trial of the ECOG-ACRIN cancer research group (E1F05)Lode J Swinnen, Anne O'Neill, Philip H Imus, et al.
Molecular Cancer Therapeutics|February 5, 2009
Interactions between PTEN and the c-Met pathway in glioblastoma and implications for therapyYunqing Li, Fadila Guessous, Charles DiPierro, et al.
Pageof 31

Showing results (161-170 of 305) with videos related to

Sort By:
Pageof 31
Acta Neurochirurgica|August 17, 2010
MR imaging characteristics of oligodendroglial tumors with assessment of 1p/19q deletion statusJonathan H Sherman, Daniel M Prevedello, Lubdha Shah, et al.
Cell Cycle (Georgetown, Tex.)|October 5, 2013
microRNA-34a promotes DNA damage and mitotic catastropheAlexander V Kofman, Jungeun Kim, So Yeon Park, et al.
Journal of Neurosurgery|October 25, 2014
Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO reviewLeland Rogers, Igor Barani, Marc Chamberlain, et al.
Mutation Research|July 29, 2018
Improved molecular karyotyping in glioblastomaIan E Burbulis, Margaret B Wierman, Matt Wolpert, et al.
American Journal of Clinical Oncology|September 17, 2016
Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397)Paul L Moots, Anne O'Neill, Harold Londer, et al.
The Prostate|March 13, 2025
Incidental Brain Metastases From Prostate Cancer Diagnosed With PSMA PET/CT and MRI: A Case Series and Literature ReviewMark Willy L Mondia, Prem P Batchala, Robert Dreicer, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 7, 2007
Functional and molecular interactions between the HGF/c-Met pathway and c-Myc in large-cell medulloblastomaYunqing Li, Fadila Guessous, Elizabeth B Johnson, et al.
The Journal of Clinical Endocrinology and Metabolism|July 30, 2010
Temozolomide treatment for aggressive pituitary tumors: correlation of clinical outcome with O(6)-methylguanine methyltransferase (MGMT) promoter methylation and expressionZachary M Bush, Janina A Longtine, Tracy Cunningham, et al.
Oncotarget|February 9, 2018
Phase II study of rituximab given in conjunction with standard chemotherapy in primary central nervous system lymphoma (PCNSL): a trial of the ECOG-ACRIN cancer research group (E1F05)Lode J Swinnen, Anne O'Neill, Philip H Imus, et al.
Molecular Cancer Therapeutics|February 5, 2009
Interactions between PTEN and the c-Met pathway in glioblastoma and implications for therapyYunqing Li, Fadila Guessous, Charles DiPierro, et al.
Pageof 31